Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neisseria Meningitidis Serogroups A & C Diseases”

21 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 21 results

Testing effectiveness (Phase 2)Study completedNCT00134719
What this trial is testing

Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines

Who this might be right for
Neisseria MeningitidisHaemophilus Influenzae Type b
GlaxoSmithKline 1,104
Large-scale testing (Phase 3)Study completedNCT01839175
What this trial is testing

Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination

Who this might be right for
Neisseria MeningitidisBacterial InfectionsVirus Diseases
Sanofi Pasteur, a Sanofi Company 350
Testing effectiveness (Phase 2)Study completedNCT00291967
What this trial is testing

Assess Immune Response Following Primary Vaccination With Tritanrix™-HepB Vaccine Mixed With 3 Formulations of Hib-MenAC Vaccine to Infants

Who this might be right for
DiphtheriaTetanusPertussis+3 more
GlaxoSmithKline 525
Large-scale testing (Phase 3)Study completedNCT01553279
What this trial is testing

Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011)

Who this might be right for
Neisseria MeningitidisBacterial InfectionsVirus Diseases
MCM Vaccines B.V. 284
Large-scale testing (Phase 3)Study completedNCT00136604
What this trial is testing

Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m

Who this might be right for
Whole Cell PertussisHaemophilus Influenzae Type bHepatitis B+3 more
GlaxoSmithKline 617
Testing effectiveness (Phase 2)Study completedNCT00127855
What this trial is testing

Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 409
Post-approval studies (Phase 4)Study completedNCT00119080
What this trial is testing

Effect of Meningococcal Conjugate Vaccine on Meningococcal Carriage

Who this might be right for
Meningitis
Centers for Disease Control and Prevention 4,000
Testing effectiveness (Phase 2)Study completedNCT00355121
What this trial is testing

Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®

Who this might be right for
Meningococcal MeningitisTetanusDiphtheria+2 more
Sanofi 882
Testing effectiveness (Phase 2)Study completedNCT00129116
What this trial is testing

3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 388
Large-scale testing (Phase 3)Study completedNCT00289783
What this trial is testing

Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 4,441
Large-scale testing (Phase 3)Study completedNCT00161928
What this trial is testing

Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants

Who this might be right for
Meningitis, Meningococcal
Pfizer 330
Testing effectiveness (Phase 2)Study completedNCT00771849
What this trial is testing

Study of Antibody Responses After a Dose of Tetravalent Meningococcal Diphtheria Conjugate Vaccine in Children

Who this might be right for
MeningitisMeningococcemia
Sanofi Pasteur, a Sanofi Company 103
Large-scale testing (Phase 3)Study completedNCT00228917
What this trial is testing

Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in Children

Who this might be right for
Whole Cell PertussisTetanusHepatitis B+3 more
GlaxoSmithKline 798
Large-scale testing (Phase 3)Study completedNCT00443846
What this trial is testing

RotaTeq® and Meningococcus C Vaccine in Healthy Infants (V260-016)

Who this might be right for
Meningitis, MeningococcalRotavirus Infections
Merck Sharp & Dohme LLC 247
Large-scale testing (Phase 3)Study completedNCT01235975
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine Given as One Dose to Healthy Subjects Above 56 Years

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 400
Large-scale testing (Phase 3)UnknownNCT02858570
What this trial is testing

Conjugate Vaccine Against Meningococcus C a Brazilian Project

Who this might be right for
Serogroup C Meningococcal Meningitis
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 1,644
Post-approval studies (Phase 4)Study completedNCT00282295
What this trial is testing

US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease

Who this might be right for
Acellular PertussisTetanusDiphtheria
GlaxoSmithKline 1,344
Post-approval studies (Phase 4)Study completedNCT00227422
What this trial is testing

Assess the Non-inferiority of GSK Biologicals' Mencevax™ ACWY (Manufactured by a New Process) vs Mencevax™ ACWY (the Already Existing Vaccine in the Market) When Given as a Single Dose to Subjects Aged 2-30 Yrs

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 324
Testing effectiveness (Phase 2)Ended earlyNCT00772629
What this trial is testing

Antibody Responses Following Meningococcal Tetravalent (A, C, Y, and W-135) Conjugate Vaccination in Healthy Adults

Who this might be right for
MeningitisMeningococcemia
Sanofi Pasteur, a Sanofi Company 18
Post-approval studies (Phase 4)Study completedNCT01129518
What this trial is testing

Can we Reduce the Number of Vaccine Injections for Children?

Who this might be right for
Invasive Meningococcal Disease
University of Oxford 404
Load More Results